Allianz Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$154M Sell
5,490,142
-231,784
-4% -$6.17M 0.16% 121
2025
Q4
$142M Sell
5,721,926
-467,367
-8% -$11.8M 0.14% 132
2025
Q3
$158M Sell
6,189,293
-3,254,189
-34% -$80.3M 0.18% 105
2025
Q2
$229M Sell
9,443,482
-3,235,204
-26% -$75.4M 0.27% 70
2025
Q1
$321M Buy
12,678,686
+2,436,039
+24% +$63.7M 0.42% 39
2024
Q4
$272M Buy
10,242,647
+3,020,784
+42% +$81.9M 0.36% 51
2024
Q3
$209M Buy
7,221,863
+3,119,251
+76% +$91M 0.29% 70
2024
Q2
$115M Buy
4,102,612
+64,160
+2% +$1.77M 0.17% 125
2024
Q1
$112M Buy
4,038,452
+972,685
+32% +$27M 0.17% 137
2023
Q4
$88.3M Sell
3,065,767
-236,251
-7% -$7.14M 0.14% 147
2023
Q3
$110M Sell
3,302,018
-205,043
-6% -$7.25M 0.18% 111
2023
Q2
$129M Sell
3,507,061
-1,462,051
-29% -$56.9M 0.23% 93
2023
Q1
$203M Buy
4,969,112
+374,075
+8% +$16.2M 0.36% 52
2022
Q4
$235M Sell
4,595,037
-1,416,658
-24% -$67.9M 0.46% 41
2022
Q3
$263M Sell
6,011,695
-3,710,955
-38% -$180M 0.54% 32
2022
Q2
$510M Sell
9,722,650
-308,977
-3% -$15.7M 0.48% 40
2022
Q1
$519M Sell
10,031,627
-1,324,106
-12% -$68.7M 0.39% 51
2021
Q4
$671M Sell
11,355,733
-1,092,626
-9% -$54.1M 0.46% 38
2021
Q3
$535M Buy
12,448,359
+7,648,286
+159% +$339M 0.42% 46
2021
Q2
$188M Buy
4,800,073
+272,175
+6% +$10.6M 0.16% 140
2021
Q1
$164M Sell
4,527,898
-999,756
-18% -$35.5M 0.16% 138
2020
Q4
$203M Sell
5,527,654
-349,222
-6% -$12.8M 0.2% 111
2020
Q3
$205M Sell
5,876,876
-1,359,853
-19% -$47.7M 0.24% 93
2020
Q2
$225M Buy
7,236,729
+478,791
+7% +$16.3M 0.26% 81
2020
Q1
$209M Sell
6,757,938
-1,568,558
-19% -$53.4M 0.28% 78
2019
Q4
$310M Sell
8,326,496
-1,492,686
-15% -$53.2M 0.28% 64
2019
Q3
$335M Sell
9,819,182
-2,222,945
-18% -$80.8M 0.33% 47
2019
Q2
$495M Sell
12,042,127
-1,608,057
-12% -$63.9M 0.46% 30
2019
Q1
$550M Sell
13,650,184
-108,440
-0.8% -$4.34M 0.54% 27
2018
Q4
$570M Buy
13,758,624
+171,616
+1% +$7.12M 0.62% 19
2018
Q3
$568M Sell
13,587,008
-784,849
-5% -$30.2M 0.51% 21
2018
Q2
$495M Sell
14,371,857
-1,483,607
-9% -$50.7M 0.48% 29
2018
Q1
$534M Buy
15,855,464
+1,350,104
+9% +$46.4M 0.51% 23
2017
Q4
$498M Buy
14,505,360
+873,141
+6% +$29.8M 0.39% 32
2017
Q3
$462M Sell
13,632,219
-2,821,962
-17% -$90.7M 0.4% 33
2017
Q2
$525M Sell
16,454,181
-899,519
-5% -$28.4M 0.5% 21
2017
Q1
$563M Sell
17,353,700
-1,992,729
-10% -$62.8M 0.55% 17
2016
Q4
$596M Buy
19,346,429
+570,334
+3% +$17.4M 0.53% 20
2016
Q3
$600M Sell
18,776,095
-1,259,976
-6% -$42.1M 0.58% 18
2016
Q2
$669M Sell
20,036,071
-3,460,242
-15% -$110M 0.71% 18
2016
Q1
$661M Buy
23,496,313
+875,456
+4% +$25M 0.75% 18
2015
Q4
$695M Buy
22,620,857
+4,795,809
+27% +$151M 0.79% 17
2015
Q3
$531M Sell
17,825,048
-1,576,320
-8% -$50.5M 0.63% 26
2015
Q2
$617M Sell
19,401,368
-2,350,210
-11% -$76.6M 0.66% 21
2015
Q1
$718M Sell
21,751,578
-823,242
-4% -$26.2M 0.82% 16
2014
Q4
$667M Sell
22,574,820
-881,902
-4% -$25.3M 0.74% 19
2014
Q3
$658M Buy
23,456,722
+2,854,700
+14% +$80.1M 0.79% 17
2014
Q2
$580M Sell
20,602,022
-2,024,558
-9% -$57.7M 0.73% 23
2014
Q1
$690M Sell
22,626,580
-1,295,472
-5% -$38.6M 0.83% 15
2013
Q4
$695M Sell
23,922,052
-4,270,454
-15% -$124M 0.89% 13
2013
Q3
$768M Sell
28,192,506
-7,267,735
-20% -$198M 1.02% 10
2013
Q2
$942M Buy
+35,460,241
New +$980M 1.34% 6

Other funds holding PFE

Allianz Asset Management's PFE Position: Q1 2026 in Review

Allianz Asset Management reduced its Pfizer (PFE) stake by 4.1% in Q1 2026, selling an estimated $6.17M and leaving 5,490,142 shares worth $154M. The position accounts for 0.16% of the portfolio, ranked #121.

Allianz Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $942M in Q2 2013. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Allianz Asset Management held 5,490,142 shares of Pfizer worth $154M as of Q1 2026.
  • Allianz Asset Management sold 231,784 Pfizer shares in Q1 2026, an estimated $6.17M.
  • Pfizer made up 0.16% of Allianz Asset Management's portfolio in Q1 2026, its #121 holding.
  • Allianz Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Allianz Asset Management's Pfizer position peaked at $942M in Q2 2013.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.